https://www.sirnamed.com/posts/sirnamed-ceo-phong-tran-speaking-at-the-2024-bio-international-conference 2026-05-07 https://www.sirnamed.com/posts/sirnamed-ceo-phong-tran-and-cmo-dr-jing-zhou-hou-attending-the-2024-rna-leaders-usa- 2026-05-07 https://www.sirnamed.com/posts/knocking-down-of-xkr8-enhances-chemotherapy-efficacy-through-modulating-tumor-immune-microenvironment 2026-05-07 https://www.sirnamed.com/posts/novel-nanoparticles-deliver-innovative-cancer-chemoimmunotherapy- 2026-05-07 https://www.sirnamed.com/posts/inhibition-of-irhom1-by-cd44-targeting-nanocarrier-for-improved-cancer-immunochemotherapy 2026-05-07 https://www.sirnamed.com/posts/targeting-xkr8-via-nanoparticle-mediated-in-situ-co-delivery-of-sirna-and-chemotherapy-drugs-for-cancer-immunochemotherapy 2026-05-07